Aminomethyl beta-secretase inhibitors for the treatment of Alzheimer's disease

Details for Australian Patent Application No. 2006206653 (hide)

Owner Merck & Co., Inc.

Inventors Stauffer, Shaun R.; Nantermet, Philippe G.; Rajapakse, Hemaka A.; Selnick, Harold G.; Coburn, Craig A.

Agent Spruson & Ferguson

Pub. Number AU-A-2006206653

PCT Pub. Number WO2006/078576

Priority 60/644,925 19.01.05 US

Filing date 13 January 2006

Wipo publication date 27 July 2006

International Classifications

A61K 31/4745 (2006.01)

C07D 271/06 (2006.01) Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms

Event Publications

12 July 2007 PCT application entered the National Phase

  PCT publication WO2006/078576 Priority application(s): WO2006/078576

14 January 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006206654-Tertiary carbinamines having substituted heterocycles, which are active as inhibitors of beta-secretase, for the treatment of Alzheimer's disease

2006206652-Mitotic kinesin inhibitors